Author: Maslow, Joel
Title: GeneOne Life Science Document date: 2018_10_26
ID: w7hf3kji_17
Snippet: DNA-based therapies are reaching a mature stage of development overall. GeneOne through its vertical integration in DNA, and now mRNA, plasmid manufacture is uniquely positioned to rapidly respond to new infectious disease threats. Our development team has moved forward unique and highly functional therapeutics that address a variety of diseases meeting key medical needs......
Document: DNA-based therapies are reaching a mature stage of development overall. GeneOne through its vertical integration in DNA, and now mRNA, plasmid manufacture is uniquely positioned to rapidly respond to new infectious disease threats. Our development team has moved forward unique and highly functional therapeutics that address a variety of diseases meeting key medical needs.
Search related documents:
Co phrase search for related documents- disease threat and infectious disease threat: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- disease threat and medical need: 1
- disease threat and new infectious disease threat: 1, 2, 3, 4
- dna vertical integration and vertical integration: 1
- infectious disease threat and new infectious disease threat: 1, 2, 3, 4
Co phrase search for related documents, hyperlinks ordered by date